1. Exploring the Molecular Interaction of PCOS and Endometrial Carcinoma through Novel Hyperparameter-Optimized Ensemble Clustering Approaches
   Pınar Karadayı Ataş, 2024, Mathematics CrossRef
2. Polycystic ovary syndrome and endometrial cancer risk: results from a nationwide cohort study
   C L B Frandsen et al, 2024, American Journal of Epidemiology CrossRef
3. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis
   Jie Cui et al, 2024, Frontiers in Oncology CrossRef
4. Polycystic ovary syndrome
   Elisabet Stener-Victorin et al, 2024, Nature Reviews Disease Primers CrossRef
5. Metformin for endometrial hyperplasia
   null null et al, 2024, Cochrane Database of Systematic Reviews CrossRef
6. Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016–2019
   Ahmed Abu-Zaid et al, 2024, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef
7. Liraglutide Improves PCOS Symptoms in Rats by Targeting FDX1
   Shuqing Ji et al, 2024, Reproductive Sciences CrossRef
8. ВПЛИВ ІНОЗИТОЛУ НА ЖІНОК ІЗ СИНДРОМОМ ПОЛІКІСТОЗНИХ ЯЄЧНИКІВ ТА ОЖИРІННЯМ: МЕТАБОЛІЧНІ ТА РЕПРОДУКТИВНІ АСПЕКТИ
   S. V. Khmil et al, 2024, Актуальні питання педіатрії, акушерства та гінекології CrossRef
9. Effect of basal luteinizing hormone (bLH) level on in vitro fertilization/intra-cytoplasmic injections (IVF/ICSI) outcomes in polycystic ovarian syndrome (PCOS) patients
   Zhuo Liu et al, 2023, BMC Pregnancy and Childbirth CrossRef
10. Differential Gene Expression Analysis of Human Ovarian Follicular Cumulus and Mural Granulosa Cells Under the Influence of Insulin in IVF Ovulatory Women and Polycystic Ovary Syndrome Patients Through Network Analysis
    Pankaj Pant et al, 2024, Endocrine Research CrossRef
11. Risk factors for atypical hyperplasia or endometrial cancer in premenopausal women aged ≤ 45 years with abnormal uterine bleeding
    Shina Jang et al, 2024, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef
12. Research Progress of Polycystic Ovary Syndrome and Metabolic Syndrome
    宁 马, 2023, Medical Diagnosis CrossRef
13. Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study
    Mirna Elghobashy et al, 2023, Frontiers in Endocrinology CrossRef
14. Deciphering the Role of Insulin-Like Growth Factor 1 in Endometrial Cancer in Patients With Polycystic Ovary Syndrome: Protocol for a Methodological Approach Using Cell Culture Experiments
    William Atiomo et al, 2023, JMIR Research Protocols CrossRef
15. New aspects in the diagnosis and treatment of polycystic ovary syndrome
    V. V. Efimenko et al, 2024, Meditsinskiy sovet = Medical Council CrossRef
16. Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort
    Donna Vine et al, 2024, CJC Open CrossRef
17. Talin1 regulates glucose metabolism and endometrial receptivity via GLUT-4 in patients with polycystic ovary syndrome and insulin resistance
    Jingjing Li et al, 2023, Gynecological Endocrinology CrossRef
18. The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea
    Shina Jang et al, 2024, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef